Cargando…
KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma
BACKGROUND: Lung adenocarcinoma (LUAD) is challenging in clinical practice due to the poor understanding of molecular mechanisms and limited therapeutic targets. Herein, the work aimed to use bioinformatics to identify a promising molecular target for LUAD therapy. METHODS: Differentially expressed...
Autores principales: | Li, Zhaodong, Yu, Bingxin, Qi, Fangyuan, Li, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103954/ https://www.ncbi.nlm.nih.gov/pubmed/33968780 http://dx.doi.org/10.3389/fonc.2021.670218 |
Ejemplares similares
-
Prognostic Significance of KIF11 and KIF14 Expression in Pancreatic Adenocarcinoma
por: Klimaszewska-Wiśniewska, Anna, et al.
Publicado: (2021) -
KIF11 is a potential prognostic biomarker and therapeutic target for adrenocortical carcinoma
por: Zhou, Yan, et al.
Publicado: (2023) -
MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma
por: Li, Meng, et al.
Publicado: (2022) -
Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma
por: Li, Zhaodong, et al.
Publicado: (2020) -
Extra Spindle Pole Bodies-Like 1 Serves as a Prognostic Biomarker and Promotes Lung Adenocarcinoma Metastasis
por: Nie, Zhi, et al.
Publicado: (2022)